VistaGen Therapeutics Reports Fiscal Year 2019 Results and Provides CNS Pipeline Overview
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / June 25, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
user
Dr. Jeffrey Morgan Discusses the Reality of Bioprinted Hearts for Patients With Advanced Heart Failure
Dr. Jeffrey A. Morgan is Cardiac Surgeon Specializing in the Treatment of Advanced Heart Failure with Mechanical Assist Devices and...
Premark Pharma Licenses Worldwide Rights to PMP2207 for Ophthalmic Indications and Targets a First Regulatory Approval for Blepharitis
BASEL, SWITZERLAND / ACCESSWIRE / June 25, 2019 / Premark Pharma announced today the completion of a licensing deal with...
International Cannabrands Announces La Vida Verde Signs Sales Expansion Agreement with the Bettie Janes and Receives Annual Distribution License
DENVER, CO / ACCESSWIRE / June 25, 2019 / International Cannabrands Inc. (CSE: JUJU) (the "Company") is pleased to announce...
DECN in Pact with Mega Pet Products Retailer Fetch for Pets Tripling Market For Company’s Petsure Test Strips and Genultimate! 4pets Test Strips and Meters
LOS ANGELES, CA / ACCESSWIRE / June 25, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year...
EastWest Bioscience Starts Production of CBD Pet Treats for the US Market
VANCOUVER, BC / ACCESSWIRE / June 25, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that, further...
Viveve Announces FDA 510(k) Clearance of Viveve 2.0 Next Generation System in the U.S.
Company also announces expansion of distribution network targeting gynecology practices in the Middle East through partnership with Dansys Group ENGLEWOOD,...
Aytu BioScience Announces First Clinical Results Demonstrating Clinical Utility of MiOXSYS Male Infertility Test When Used Prior to In Vitro Fertilization (IVF) Procedures
First Clinical Data Demonstrating Predictive Power of Seminal Oxidation-Reduction Potential (ORP) as a Predictor of Fertilization When Used Prior to...
Theralase Brain Cancer Pre-Clinical Research Accepted for Publication
Research Detailing Advantages of Rutherrin® PhotoDynamic Therapy in deadly brain cancer, GlioBlastoma Multiforme ("GBM") to be Published in the Journal...
CORRECTION: Ad hoc: MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer
Correction of a release disseminated on June 24, 2019. Correction of an inside information acc. to Article 17 MAR of...
Canland Health Corp. Announces Appointments of New Directors and Officers
VANCOUVER, BC / ACCESSWIRE / June 24, 2019 / Canland Health Corp. (formerly, 1155176 B.C. Ltd.) (the "Company") announces the...
Jaguar Health Regains Compliance with All Applicable Nasdaq Stock Market Listing Standards
SAN FRANCISCO, CA / ACCESSWIRE / June 24, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a...
MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 24, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX &...
ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the 2nd International Conference on Fatty Liver (ICFL 2019)
Newly Appointed Chief Commercial Officer (CCO) Renaud Maloberti to Showcase ENDRA's Breakthrough Thermo Acoustic Enhanced UltraSound (TAEUS) Technology Addressing Fatty...
Emergent Health Corp. (EMGE: OTC Markets)-Further Progress Report
KING OF PRUSSIA, PA / ACCESSWIRE / June 24, 2019 / Emergent Health Corp. (the "Company") (OTC PINK: EMGE) purpose...
MiOXSYS(R) Male Infertility Test Will be Featured in Product Theatre Symposium at 35th Annual Meeting of the European Society of Human Reproduction and Embryology
ENGLEWOOD, CO / ACCESSWIRE / June 24, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on...
Evotec, Sensyne Health, The University Of Oxford, OSI, and OUI Create New Bridge Partnership ‘LAB10X’ In Digital Health
- LAB10X FOCUSES ON ACCELERATING DATA-DRIVEN HEALTHCARE SOLUTIONS POWERED BY ARTIFICIAL INTELLIGENCE ("AI") - GOAL IS TO ACCELERATE PROOF-OF-CONCEPT IN...
Top Orthodontics Experts Exchanged Experiences of Class III Malocclusion at the 2019 Orthodontic Conference of Jinan University
NEW YORK, NY / ACCESSWIRE / June 23, 2019 / Recently, the 2019 Orthodontic Conference of Jinan University and 3rd...
MorphoSys Presents Primary Analysis Data from L-MIND Study of Tafasitamab (MOR208) in combination with Lenalidomide in r/r DLBCL at ICML 2019
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 22, 2019 / MorphoSys Presents Primary Analysis Data from L-MIND Study of...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2019 and Provides Conference Call Information
Conference Call Scheduled for Monday, June 24h at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 21, 2019 /...